Analyst Price Targets — MDT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 18, 2026 12:50 pm | — | Robert W. Baird | $100.00 | $96.41 | TheFly | Medtronic price target lowered to $100 from $103 at Baird |
| February 18, 2026 10:12 am | Matt Miksic | Barclays | $118.00 | $96.41 | TheFly | Medtronic price target raised to $118 from $116 at Barclays |
| February 9, 2026 11:14 am | — | Needham | $121.00 | $102.90 | TheFly | Medtronic upgraded to Buy from Hold at Needham |
| February 4, 2026 2:24 pm | — | UBS | $104.00 | $103.38 | TheFly | Medtronic price target raised to $104 from $103 at UBS |
| January 30, 2026 2:30 pm | Larry Biegelsen | Wells Fargo | $114.00 | $101.79 | TheFly | Medtronic resumed with an Overweight at Wells Fargo |
| January 9, 2026 11:49 am | — | Bernstein | $112.00 | $98.69 | TheFly | Medtronic price target raised to $112 from $111 at Bernstein |
| January 8, 2026 10:59 am | Matt Miksic | Barclays | $116.00 | $99.77 | TheFly | Medtronic price target raised to $116 from $111 at Barclays |
| December 18, 2025 2:13 pm | Richard Newitter | Truist Financial | $107.00 | $99.14 | TheFly | Medtronic price target lowered to $107 from $110 at Truist |
| December 16, 2025 10:38 am | — | Robert W. Baird | $103.00 | $98.67 | TheFly | Medtronic price target lowered to $103 from $109 at Baird |
| November 20, 2025 11:16 am | — | Barclays | $111.00 | $100.34 | TheFly | Medtronic price target raised to $111 from $109 at Barclays |
Latest News for MDT
111 Capital acquired a new stake in Medtronic PLC (NYSE: MDT) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,036 shares of the medical technology company's stock, valued at approximately $1,146,000. Several other hedge funds also recently bought and sold shares
Intuitive Surgical has been growing strongly as it builds out its surgical robotics business. This medical device competitor has just launched its own surgical robot in the United States.
Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses.
Artisan Partners Limited Partnership lifted its stake in Medtronic PLC (NYSE: MDT) by 2.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,234,550 shares of the medical technology company's stock after buying an additional 31,314 shares during the period.
Medtronic PLC (NYSE: MDT - Get Free Report) EVP Harry Skip Kiil sold 52,524 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $97.71, for a total transaction of $5,132,120.04. Following the completion of the sale, the executive vice president owned 32,768 shares in
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.